Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New PR on share buyback
Reply New Message
Prev Message Back To Forum Threaded View Next Message

I don't recall the limit being 1MM shares per month. I thought they could buy shares using up to 10% of licensing revenue received.

I'm pretty sure about this, but I'm open to correction.

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply